651 related articles for article (PubMed ID: 18822302)
21. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
22. A rapid and cell-free assay to test the activity of lynch syndrome-associated MSH2 and MSH6 missense variants.
Drost M; Zonneveld JB; van Hees S; Rasmussen LJ; Hofstra RM; de Wind N
Hum Mutat; 2012 Mar; 33(3):488-94. PubMed ID: 22102614
[TBL] [Abstract][Full Text] [Related]
23. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the signature motif in MutS affect ATP-induced clamp formation and mismatch repair.
Acharya S
Mol Microbiol; 2008 Sep; 69(6):1544-59. PubMed ID: 18673453
[TBL] [Abstract][Full Text] [Related]
25. Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.
Wielders EA; Hettinger J; Dekker R; Kets CM; Ligtenberg MJ; Mensenkamp AR; van den Ouweland AM; Prins J; Wagner A; Dinjens WN; Dubbink HJ; van Hest LP; Menko F; Hogervorst F; Verhoef S; te Riele H
J Med Genet; 2014 Apr; 51(4):245-53. PubMed ID: 24501230
[TBL] [Abstract][Full Text] [Related]
26. Loss of DNA mismatch repair function and cancer predisposition in the mouse: animal models for human hereditary nonpolyposis colorectal cancer.
Edelmann L; Edelmann W
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):91-9. PubMed ID: 15264277
[TBL] [Abstract][Full Text] [Related]
27. Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
Stella A; Surdo NC; Lastella P; Barana D; Oliani C; Tibiletti MG; Viel A; Natale C; Piepoli A; Marra G; Guanti G
Clin Genet; 2007 Feb; 71(2):130-9. PubMed ID: 17250661
[TBL] [Abstract][Full Text] [Related]
28. Report on de-novo mutation in the MSH2 gene as a rare event in hereditary nonpolyposis colorectal cancer.
Morak M; Laner A; Scholz M; Madorf T; Holinski-Feder E
Eur J Gastroenterol Hepatol; 2008 Nov; 20(11):1101-5. PubMed ID: 19047842
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.
Gammie AE; Erdeniz N; Beaver J; Devlin B; Nanji A; Rose MD
Genetics; 2007 Oct; 177(2):707-21. PubMed ID: 17720936
[TBL] [Abstract][Full Text] [Related]
30. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome.
Kariola R; Raevaara TE; Lönnqvist KE; Nyström-Lahti M
Hum Mol Genet; 2002 May; 11(11):1303-10. PubMed ID: 12019211
[TBL] [Abstract][Full Text] [Related]
31. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
33. Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer.
Ponti G; Losi L; Pellacani G; Wannesson L; Cesinaro AM; Venesio T; Petti C; Seidenari S
Br J Dermatol; 2008 Jul; 159(1):162-8. PubMed ID: 18460031
[TBL] [Abstract][Full Text] [Related]
34. Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.
Ellison AR; Lofing J; Bitter GA
Nucleic Acids Res; 2004; 32(18):5321-38. PubMed ID: 15475387
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer in an MSH2 gene mutation carrier.
Westenend PJ; Schütte R; Hoogmans MM; Wagner A; Dinjens WN
Hum Pathol; 2005 Dec; 36(12):1322-6. PubMed ID: 16311127
[TBL] [Abstract][Full Text] [Related]
36. Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes.
Ou J; Niessen RC; Lützen A; Sijmons RH; Kleibeuker JH; de Wind N; Rasmussen LJ; Hofstra RM
Hum Mutat; 2007 Nov; 28(11):1047-54. PubMed ID: 17594722
[TBL] [Abstract][Full Text] [Related]
37. Mouse mismatch repair gene Msh2 is not essential for transcription-coupled repair of UV-induced cyclobutane pyrimidine dimers.
Sonneveld E; Vrieling H; Mullenders LH; van Hoffen A
Oncogene; 2001 Jan; 20(4):538-41. PubMed ID: 11313985
[TBL] [Abstract][Full Text] [Related]
38. Senescence-dependent MutS alpha dysfunction attenuates mismatch repair.
Chang IY; Jin M; Yoon SP; Youn CK; Yoon Y; Moon SP; Hyun JW; Jun JY; You HJ
Mol Cancer Res; 2008 Jun; 6(6):978-89. PubMed ID: 18567801
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
40. [Study on the germline mutation of MSH6 gene in Chinese hereditary nonpolyposis colorectal cancer pedigrees using PCR based sequencing].
Yan SY; Zhou XY; Cai SJ; Yu BH; Zhang TM; Li XM; Lu YM; Zhou HH; Mo SJ; Du X; Shi DR
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):640-5. PubMed ID: 18067074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
